Tag: Multiple Myeloma

Orphan Drug Designation for Multiple Myeloma Patients

August 1, 2025

Orphan Drug Designation for Multiple Myeloma Patients

$Linvoseltamab for Refractory Multiple Myeloma: New Hope$

July 25, 2025

Linvoseltamab for Refractory Multiple Myeloma: New Hope

Transplant-Ineligible Older Patient Therapy Strategies

July 22, 2025

Transplant-Ineligible Older Patient Therapy Strategies

FDA Panel Rejects Belantamab Mafodotin Myeloma Treatments

July 18, 2025

FDA Panel Rejects Belantamab Mafodotin Myeloma Treatments

Web Analytics